Score Overview
Explore the 2021 public Archive ranking →
Where Integra LifeSciences Holdings has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 30 years of fundamentals. IART does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 16.27 | — |
1 Year2025-09-26 | $ 13.20 | 23.26% |
5 Years2021-09-28 | $ 70.53 | -76.93% |
10 Years2016-09-28 | $ 42.59 | -61.79% |
20 Years2006-09-28 | $ 13.41 | 21.37% |
30 Years1996-09-27 | $ 4.36 | 273.12% |
All Time1995-08-16 | $ 3.29 | 394.14% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1995-08-16 |
|---|---|---|---|---|---|---|---|
| Price | $ 16.27 | $ 13.20 | $ 70.53 | $ 42.59 | $ 13.41 | $ 4.36 | $ 3.29 |
| Return | — | 23.26% | -76.93% | -61.79% | 21.37% | 273.12% | 394.14% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 1.64B | -$ 7M | $ 274M |
| 2025 | $ 1.63B | -$ 516M | $ 263M |
| 2024 | $ 1.61B | -$ 6M | $ 273M |
| 2023 | $ 1.54B | $ 67M | $ 309M |
| 2022 | $ 1.55B | $ 180M | $ 456M |
| 2021 | $ 1.54B | $ 169M | $ 513M |
| 2020 | $ 1.37B | $ 133M | $ 470M |
| 2019 | $ 1.51B | $ 50M | $ 198M |
| 2018 | $ 1.47B | $ 60M | $ 138M |
| 2017 | $ 1.18B | $ 64M | $ 174M |
| 2016 | $ 992M | $ 74M | $ 102M |
| 2015 | $ 882M | -$ 3M | $ 48M |
| 2014 | $ 928M | $ 34M | $ 71M |
| 2013 | $ 836M | -$ 16M | $ 120M |
| 2012 | $ 830M | $ 41M | $ 96M |
| 2011 | $ 780M | $ 27M | $ 100M |
| 2010 | $ 732M | $ 65M | $ 128M |
| 2009 | $ 682M | $ 50M | $ 71M |
| 2008 | $ 654M | $ 34M | $ 183M |
| 2007 | $ 550M | $ 33M | $ 57M |
| 2006 | $ 419M | $ 29M | $ 22M |
| 2005 | $ 277M | $ 37M | $ 127M |
| 2004 | $ 229M | $ 17M | $ 100M |
| 2003 | $ 185M | $ 26M | $ 108M |
| 2002 | $ 112M | $ 35M | $ 98M |
| 2001 | $ 93M | $ 26M | $ 66M |
| 2000 | $ 64M | -$ 11M | $ 15M |
| 1999 | $ 42M | -$ 6M | $ 23M |
| 1998 | $ 17M | -$ 12M | $ 5M |
| 1997 | $ 14M | -$ 17M | $ 2M |
| 1996 | $ 13M | -$ 7M | $ 11M |
| IPO1995 | $ 10M | -$ 25M | $ 4M |
Integra LifeSciences Holdings fundamental performance
Between 2005 and 2025, revenue grew from $ 277M to $ 1.63B and net income went from $ 37M to -$ 516M. Revenue increased in 17 of those 20 years; net income in 11.
Across Integra LifeSciences Holdings's full reported history, from 1995 to 2025, revenue grew from $ 10M to $ 1.63B and net income went from -$ 25M to -$ 516M. Revenue increased in 90% of the years measured; net income in 55%.
Integra LifeSciences Holdings currently holds a 20-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.
Membership
Explore IART with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
